US – federal: The House of Representatives Committee on Oversight and Accountability has announced that it is investigating the Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP). Republican committee chairman James Comer has written to FDA commissioner Robert Califf, accusing the CTP of failing to effectively define and administer its tobacco and nicotine regulatory programmes, “[fostering] uncertainty in the marketplace and [allowing] unsafe and » Continue Reading.
I'm already a subscriber

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation